Ciltacabtagene autoleucel for treating relapsed or refractory multiple myeloma

Research output: Book/ReportCommissioned report

Original languageEnglish
PublisherNational Institute for Health and Care Excellence
Commissioning bodyNational Institute for Health and Care Excellence
Publication statusPublished - 17 May 2023

Cite this